Literature DB >> 17984117

A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.

Byung Lan Lee1, Woo Ho Kim, Jieun Jung, Sung Jin Cho, Jong-Wan Park, Jihyen Kim, Hee-Yong Chung, Mee Soo Chang, Seon Young Nam.   

Abstract

Underlying mechanisms involved in the activation of hypoxia-inducible factor-1 (HIF-1) in cancer cells are diverse and cell type specific. Although both HIF-1alpha and AKT (protein kinase B) have been implicated in gastric tumor promotion and angiogenesis, it remains unclear whether HIF-1 mediates the role of AKT in terms of promoting vascular endothelial growth factor (VEGF) expression. The present study was performed to investigate the correlation between HIF-1alpha activation and AKT activation in gastric cancer using human gastric cancer specimens, in vitro cell experiments and in vivo animal experiments. Immunohistochemistry performed on tissue array slides containing 268 surgical specimens of gastric carcinomas showed immunoreactivity for HIF-1alpha in 29% of samples. Moreover, HIF-1alpha was positively associated with phosphorylated AKT (pAKT) (P = 0.002) or VEGF (P = 0.002), and the immunoreactivities of pAKT and VEGF were positively correlated (P < 0.001). Western blot analysis and reverse transcription-polymerase chain reaction in cell experiments revealed that the over-expression of constitutively active AKT (CA-AKT) promotes the expressions of HIF-1alpha protein and VEGF messenger ribonucleic acid in Seoul national university (SNU)-216 and SNU-668 gastric cancer cells under normoxic conditions, whereas kinase-dead mutant of AKT down-regulated these expressions under the same conditions. Xenografts in nude mice derived from stable gastric cancer cells over-expressing CA-AKT showed higher tumor incidence, larger tumor volumes, higher microvessel density and stronger HIF-1alpha immunoreactivity than those derived from vector control cells. Thus, we propose that the hypoxia-independent promotion of the AKT-HIF-1alpha-VEGF pathway contributes, at least in part, to gastric cancer tumorigenesis and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984117     DOI: 10.1093/carcin/bgm232

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  27 in total

Review 1.  Immunometabolism: A new target for improving cancer immunotherapy.

Authors:  Chunqing Guo; Shixian Chen; Wenjie Liu; Yibao Ma; Juan Li; Paul B Fisher; Xianjun Fang; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

2.  Repression of PES1 expression inhibits growth of gastric cancer.

Authors:  Jieping Li; Xiaodong Zhou; Xiaopeng Lan; Guobin Zeng; Xuping Jiang; Zongming Huang
Journal:  Tumour Biol       Date:  2015-09-30

3.  Non-hypoxic stabilization of HIF-Iα during coordinated interaction between Akt and angiopoietin-1 enhances endothelial commitment of bone marrow stem cells.

Authors:  Vien Khach Lai; Muhammad Rizwan Afzal; Muhammad Ashraf; Shujia Jiang; Husnain Kh Haider
Journal:  J Mol Med (Berl)       Date:  2012-01-12       Impact factor: 4.599

4.  The increased expression of DEC1 gene is related to HIF-1α protein in gastric cancer cell lines.

Authors:  Yan Zheng; Xiaohong Shi; Min Wang; Yanfei Jia; Binbin Li; Yi Zhang; Qinghua Liu; Yunshan Wang
Journal:  Mol Biol Rep       Date:  2011-07-21       Impact factor: 2.316

5.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

Authors:  Siddavaram Nagini
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

6.  Angiogenic factors are increased in circulating granulocytes and CD34+ cells of myeloproliferative neoplasms.

Authors:  Tijana Subotički; Olivera Mitrović Ajtić; Bojana B Beleslin-Čokić; Ronny Nienhold; Miloš Diklić; Dragoslava Djikić; Danijela Leković; Tanja Bulat; Dragana Marković; Mirjana Gotić; Constance T Noguchi; Alan N Schechter; Radek C Skoda; Vladan P Čokić
Journal:  Mol Carcinog       Date:  2016-07-08       Impact factor: 4.784

7.  Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancer.

Authors:  Xiao-Hong Liu; Chen-Guang Bai; Yang Yuan; De-Jun Gong; Sheng-Dong Huang
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

8.  Activated Akt as an indicator of prognosis in gastric cancer.

Authors:  Caterina Cinti; Carla Vindigni; Alessandra Zamparelli; Dario La Sala; Maria Carmela Epistolato; Daniele Marrelli; Gabriele Cevenini; Piero Tosi
Journal:  Virchows Arch       Date:  2008-10-08       Impact factor: 4.064

9.  PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines.

Authors:  Norazizah Shafee; Stefan Kaluz; Ning Ru; Eric J Stanbridge
Journal:  Cancer Lett       Date:  2009-04-01       Impact factor: 8.679

10.  Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT.

Authors:  S McKenzie; S Sakamoto; N Kyprianou
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.